Know your odds: Essex resident offers genetic counseling for cancer

Posted

Two words define Essex native Laura Colello’s work as a genetic counselor: family history.

It’s the most important factor in determining a patient’s risk for cancer. It’s also what attracted Colello to the job.

“My mom had cancer, and my mother-in-law had cancer,” she said. “I’m comfortable with cancer – I’m not comfortable with babies with birth defects.”

Colello, then, focuses on genetic counseling related to the disease at UVM Medical Center’s Familial Cancer Program. She and another full-time counselor can see up to 25 families a week.

Their shared goal is determining if someone has a higher risk of developing cancer based on genetic factors, and, if so, changing screening recommendations for potential early detection.

Colello likens the genetic process to spellchecking a book: “Typos” happen when cells replicate, but cancer occurs when one cell accumulates too many typos to decipher its own instructions.

Genetic counseling, then, looks for those typos – spellchecking – and also for missing or added “chunks of the book.”

Additionally, counselors identify relatives who may also carry a higher risk for cancer and help patients understand what their results mean.

That interpretation of nuanced genetic data is a key component of UVM’s program, and Colello regularly finds patients travel out-of-state – particularly from upstate New York – to access counseling.

“If we identify somebody with a genetic mutation, we’re going to help them distribute that information to their family,” Colello said.

In a field where knowledge is power, that information could be lifesaving, particularly when it comes to breast cancer.

Perhaps the most recognizable hereditary gene mutations, BRCA1 and BRCA2 carry an elevated risk of breast cancer for those who inherit them. While the average American woman has a roughly 12 percent chance of developing breast cancer in her lifetime, BRCA1 and 2 mutations up that risk to a staggering 43 to 87 percent, the National Cancer Institute says.

That’s because BRCA mutations damage the gene that normally repairs damaged DNA. Defective and unable to suppress uncontrolled cell division, that can lead to cancer, particularly breast and ovarian.

“Sometimes we have these sad stories where a woman comes in and she’s got ovarian cancer, and then she finds out she has a BRCA mutation, and it turns out her cousin knew she had one 10 years ago and never notified [her],” Colello said. “That’s just heartbreaking.”

Beyond BRCA, Colello will also test for newer genes like ATM, CHEK2, PALB2 and BRIP1. Mutations to these genes carry a moderately elevated risk of breast cancer – 23 to 48 percent for CHEK2, for instance, and 17 to 58 percent for PALB2 – and can alter a woman’s recommended screening, including by starting younger.

“The most common thing is that, for breast cancer, people get diagnosed with early cancers at their first MRI,” Colello said.

That happened to one genetic counseling patient in her 60s. Her family history “wasn’t that suspicious,” Colello said, but she started having MRIs, which detected early breast cancer.

“She probably just needed a lumpectomy and no other treatment,” Colello said. That, of course, is a success story.

Genetic testing in the last five years has “really exploded,” Colello explained, following a 2013 U.S. Supreme Court decision that ruled genes could not be patented.

Prior to that, a Utah laboratory held the patents for BRCA1 and 2, “so they were the only game in town,” Colello said.

After the court struck that down, the market cracked open, leading to a proliferation of labs, new research and, with that, new genes to test.

“If [someone] had just BRCA1 and 2 testing in the past, there is more to offer now,” Colello said. “Sometimes we’re seeing people again.”

Patients don’t need a doctor’s referral for genetic counseling, either. Ideal candidates for the Familial Cancer Program include people diagnosed with cancer at a young age (generally before 50), people with multiple or bilateral cancers, people with rare cancers (like male breast cancer), families with many cases of cancer and families that fit a pattern of known hereditary cancer, like breast, ovarian, colon and uterine cancers.

Anyone can come in for counseling, but most cancer is sporadic, not hereditary: Only about 5 to 10 percent of cancers are inherited, Colello said, whereas 65 percent of cancer cases happen simply by chance. Familial cancer accounts for 15 to 25 percent of cases.

Counseling begins with a patient questionnaire, and Colello draws out a family tree to help determine the chance of hereditary factors.

“Even if somebody doesn’t have something hereditary, we might change screening recommendations just based on their family history,” she said. “So if your mom had breast cancer at 40 and there’s no genetic testing, you’re actually going to start your mammograms at 30 or 35.”

That’s a full 10 to 15 years before the American Cancer Society recommends the average woman in good health receive her first screening.

Presumed expense and potential insurance discrimination are common barriers to a patient accessing genetic counseling, Colello said. She outright dispels the former – following the 2013 court decision, “there’s other labs now, and they are all kind of jockeying for our attention,” she said, which helps tamp down prices.

“Come see us, and we’ll see what we can do,” she added. “The bottom line is the majority of people pay less than $100 for this.”

The insurance issue is a bit hairier, mainly due to a lack of hard evidence either way. The 2008 Genetic Information Nondiscrimination Act protects patients from discrimination in health insurance or employment, Colello noted, but there’s nothing in the law about life insurance or long-term disability.

“We don’t have any proof that people are discriminated against [for genetic purposes],” Colello said, but anxiety over legal implications still exists.

Before GINA’s passage, though, genetic counseling was a different world entirely: People were testing under fake names and paying in cash, Colello said.

Despite a changed – and expanding – landscape, Colello herself has not undergone genetic testing. Though her mother had ovarian cancer, a known hereditary variety, pathology indicated her disease was not associated with BRCA mutations. Add to that a lack of family history, and Colello is “just not that concerned” about her own risk.

Still, she subscribes to the widely held belief that knowledge is power and tells her patients as much.

“You don’t want it, but it’s almost good news,” she said. “Because for some patients, it’s like, ‘Why did I get breast cancer at 35?’ It’s a reason you got breast cancer at 35. It wasn’t your fault – you inherited something.”

To learn more about UVM Medical Center’s Familial Cancer Program or to schedule genetic counseling, call 847-8400.

Editor’s note: This story is part of the Sun’s annual Breast Cancer Awareness section. 

Comments

No comments on this item Please log in to comment by clicking here